The role of pelvic lymph node dissection during radical prostatectomy in patients with Gleason 6 intermediate-risk prostate cancer

Objective - To analyze the benefit of pelvic lymph node dissection (PLND) in patients with biopsy Gleason grade ≤ 6, cT ≤ 2b, and prostate-specific antigen (PSA) 10-20 ng/mL (main study cohort), as the indication for PLND during radical prostatectomy remains uncertain in patients with nonhigh-risk t...

Full description

Saved in:
Bibliographic Details
Main Authors: Mandel, Philipp (Author) , Kriegmair, Maximilian (Author)
Format: Article (Journal)
Language:English
Published: July 2016
In: Urology
Year: 2016, Volume: 93, Pages: 141-146
ISSN:1527-9995
DOI:10.1016/j.urology.2016.02.046
Online Access:Verlag, Volltext: https://doi.org/10.1016/j.urology.2016.02.046
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0090429516002764
Get full text
Author Notes:Philipp Mandel, Maximilian C. Kriegmair, Valia Veleva, Georg Salomon, Markus Graefen, Hartwig Huland, and Derya Tilki

MARC

LEADER 00000caa a2200000 c 4500
001 1668788101
003 DE-627
005 20220816185229.0
007 cr uuu---uuuuu
008 190708s2016 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.urology.2016.02.046  |2 doi 
035 |a (DE-627)1668788101 
035 |a (DE-599)KXP1668788101 
035 |a (OCoLC)1341232202 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Mandel, Philipp  |e VerfasserIn  |0 (DE-588)1177745747  |0 (DE-627)1048898873  |0 (DE-576)517508516  |4 aut 
245 1 4 |a The role of pelvic lymph node dissection during radical prostatectomy in patients with Gleason 6 intermediate-risk prostate cancer  |c Philipp Mandel, Maximilian C. Kriegmair, Valia Veleva, Georg Salomon, Markus Graefen, Hartwig Huland, and Derya Tilki 
264 1 |c July 2016 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.07.2019 
520 |a Objective - To analyze the benefit of pelvic lymph node dissection (PLND) in patients with biopsy Gleason grade ≤ 6, cT ≤ 2b, and prostate-specific antigen (PSA) 10-20 ng/mL (main study cohort), as the indication for PLND during radical prostatectomy remains uncertain in patients with nonhigh-risk tumors. - Materials and Methods - The main study cohort included 1383 patients with low intermediate-risk cancer undergoing radical prostatectomy with or without PLND between 1994 and 2013. Positive lymph node (LN) rates were reported and compared to patients with higher (≥20 ng/mL; n = 314) and lower (<10 ng/mL; n = 6861) PSA. Oncological outcome was assessed by Cox regressions in patients with a minimum follow-up of 5years. - Results - In the main study cohort (PSA 10-20 ng/mL), PLND was performed in 867 (62.7%) patients with a median number of removed LNs of 11 (interquartile range 16-6). Positive LNs were detected in 3.3% of these patients. Compared to the main study cohort, patients with preoperatively higher PSA ≥ 20 ng/mL (or lower PSA < 10 ng/ml) underwent PLND in 83.8% (32.7%) of the cases, with 8.0% (1.8%) showing positive LNs. Median follow-up in the main study cohort was 84.5 months. Biochemical recurrence (BCR) occurred in 20.6% of these men. The 5-year and 10-year BCR-free survival rates were 82.2% and 75.6% for those with PLND, and 83.4% and 75.8% for patients without PLND. PLND was not a significant factor influencing BCR-free, metastasis-free, or cancer-specific survival in the main study cohort. - Conclusion - Positive LNs are rare in patients with Gleason grade ≤ 6, cT ≤ 2b, and PSA 10-20 ng/mL. Performing PLND had no statistical influence on oncologic outcome and therefore should be decided upon on an individual basis. 
700 1 |a Kriegmair, Maximilian  |d 1987-  |e VerfasserIn  |0 (DE-588)1049742745  |0 (DE-627)782573347  |0 (DE-576)403726840  |4 aut 
773 0 8 |i Enthalten in  |t Urology  |d Amsterdam [u.a.] : Elsevier Science, 1973  |g 93(2016), Seite 141-146  |h Online-Ressource  |w (DE-627)320491064  |w (DE-600)2011025-X  |w (DE-576)121191044  |x 1527-9995  |7 nnas  |a The role of pelvic lymph node dissection during radical prostatectomy in patients with Gleason 6 intermediate-risk prostate cancer 
773 1 8 |g volume:93  |g year:2016  |g pages:141-146  |g extent:6  |a The role of pelvic lymph node dissection during radical prostatectomy in patients with Gleason 6 intermediate-risk prostate cancer 
856 4 0 |u https://doi.org/10.1016/j.urology.2016.02.046  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0090429516002764  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190708 
993 |a Article 
994 |a 2016 
998 |g 1049742745  |a Kriegmair, Maximilian  |m 1049742745:Kriegmair, Maximilian  |d 60000  |d 63100  |e 60000PK1049742745  |e 63100PK1049742745  |k 0/60000/  |k 1/60000/63100/  |p 2 
999 |a KXP-PPN1668788101  |e 3491993482 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title":"The role of pelvic lymph node dissection during radical prostatectomy in patients with Gleason 6 intermediate-risk prostate cancer","title_sort":"role of pelvic lymph node dissection during radical prostatectomy in patients with Gleason 6 intermediate-risk prostate cancer"}],"person":[{"family":"Mandel","role":"aut","given":"Philipp","display":"Mandel, Philipp"},{"role":"aut","given":"Maximilian","display":"Kriegmair, Maximilian","family":"Kriegmair"}],"name":{"displayForm":["Philipp Mandel, Maximilian C. Kriegmair, Valia Veleva, Georg Salomon, Markus Graefen, Hartwig Huland, and Derya Tilki"]},"relHost":[{"title":[{"title_sort":"Urology","title":"Urology"}],"language":["eng"],"part":{"volume":"93","year":"2016","text":"93(2016), Seite 141-146","extent":"6","pages":"141-146"},"pubHistory":["1.1973 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"320491064","origin":[{"dateIssuedKey":"1973","publisher":"Elsevier Science","dateIssuedDisp":"1973-","publisherPlace":"Amsterdam [u.a.]"}],"id":{"eki":["320491064"],"issn":["1527-9995"],"zdb":["2011025-X"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"The role of pelvic lymph node dissection during radical prostatectomy in patients with Gleason 6 intermediate-risk prostate cancerUrology","note":["Gesehen am 01.04.05","Ungezählte Beil.: Supplement"]}],"note":["Gesehen am 08.07.2019"],"id":{"doi":["10.1016/j.urology.2016.02.046"],"eki":["1668788101"]},"physDesc":[{"extent":"6 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1668788101","origin":[{"dateIssuedDisp":"July 2016","dateIssuedKey":"2016"}]} 
SRT |a MANDELPHILROLEOFPELV2016